Global Stem Cells Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431633
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • BIOTIME, Inc.
  • Celgene Corporation
  • CellGenix GmbH
  • Genea BioCells
  • Pluristem
  • TiGenix
  • MORE
Stem Cells Market - Market Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global stem cells market was valued at US$ 5,231.7 Mn in 2016, and is expected to reach US$ 13,731.5 Mn by 2025 expanding at a CAGR of 10.50% from 2017 to 2025.

Market Insights

Stem cells therapy will be transforming the medical treatment in the coming decades with a few factors yet to be addressed which surfaced during clinical trials studies such as intersection of cGMP guidelines with GCPs, and temperature control factors where it is easy to transport the cells within research centre but challenge arises when it is transferred to different countries. Additionally once the stem cells are administered to volunteers enrolled under clinical trials the monitoring of safety is huge concern. The ICH guidelines regarding the stem cells therapy needs to be revised as they are 20 years old. In 2016, adult stem cells segment dominated the market due to key market drivers such as its high compatibility with human body, low contamination during the sub culturing protocols and has advantages of avoiding ethical issues associated with the use of other human cells. Induced pluripotent stem cells segment will be the fastest growing market throughout the forecast period 2017-2025, as it possess application in regenerative medicines, drug screening, disease modelling, and organoid generation. In 2016, regenerative medicine dominated the application segment due to factors such as rising prevalence of chronic diseases requiring immediate medical intervention, and it provides novel opportunities to the pharmaceutical companies by identifying the lead candidate and development of novel drugs. Drug discovery and development segment will be the fastest growing market throughout the forecast period 2017-2025, due to the factors such as increasing demand for stem cell technology from pharmaceutical giants to reduce the high attrition rate of late stage drug candidates and build innovative cellular models. In base year 2016, autologous stem cell therapy held the largest market primarily due to factors such as no immunological rejection and no requirement of anesthesia during stem cells transfer to patient. Allogenic stem cell therapy will be the fastest growing segment throughout the forecast period 2017-2025, due to factors such as rising demand in oncology as it gives the graft versus cancer effect in the host and donor can donate more white blood cells whenever required.

In 2016, North America held the largest revenue share mainly due to factors such as rising prevalence of chronic diseases, enhanced government spending in the research and development facilities studying stem cells therapy and affordable reimbursement scenario. Asia Pacific will be the fastest growing market throughout the forecast period 2017-2025, majorly due to factors such as technological advancement in the extraction and harvesting of stem cells for therapeutic applications and supportive regulatory environment for stem cells product.

Key Market Movements:
  • Rising prevalence of chronic diseases requiring immediate medical intervention
  • Technological advancement in the stem cells isolation and harvesting procedures
  • Supportive regulatory environment for stem cells products
  • Merger and acquisition between healthcare insurance providers and specialty clinics has made it possible for patients to procure stem cell therapy reimbursement
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BIOTIME, Inc.
  • Celgene Corporation
  • CellGenix GmbH
  • Genea BioCells
  • Pluristem
  • TiGenix
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Stem Cells Market Portraiture
2.1.1. Global Stem Cells Market, by Product, 2016
2.1.2. Global Stem Cells Market, by Application, 2016
2.1.3. Global Stem Cells Market, by Therapy, 2016
2.1.4. Global Stem Cells Market, by Geography, 2016

Chapter 3. Stem Cells Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Stem Cells Market, by Product
4.3. Adult Stem Cells
4.3.1. Neuronal Stem Cells
4.3.2. Hematopoietic Stem Cells
4.3.3. Mesenchymal Stem Cells
4.3.4. Umbilical Cord Stem Cells
4.3.5. Others
4.4. Human Embryonic Stem Cells
4.5. Induced Pluripotent Stem Cells
4.6. Very Small Embryonic Like Stem Cells

Chapter 5. Global Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global Stem Cells Market, by Application
5.3. Regenerative Medicine
5.3.1. Neurology
5.3.2. Orthopedics
5.3.3. Oncology
5.3.4. Hematology
5.3.5. Cardiovascular Diseases
5.3.6. Diabetes
5.3.7. Liver Disorders
5.3.8. Others
5.4. Drug Discovery and Development

Chapter 6. Global Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
6.1. Overview
6.2. Attractive Investment Proposition: Global Stem Cells Market, by Therapy
6.3. Autologous Stem Cell Therapy
6.4. Allogeneic Stem Cell Therapy

Chapter 7. Global Stem Cells Market, by Geography, 2015 - 2025 (US$ Mn)
7.1. Overview
7.2. North America Stem Cells Market Analysis, 2015 - 2025
7.2.1. North America Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
7.2.2. North America Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
7.2.3. North America Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
7.2.4. North America Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Stem Cells Market Analysis, 2015 - 2025
7.3.1. Europe Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
7.3.2. Europe Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
7.3.3. Europe Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
7.3.4. Europe Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. France
7.3.4.4. Rest of Europe
7.4. Asia Pacific Stem Cells Market Analysis, 2015 - 2025
7.4.1. Asia Pacific Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
7.4.2. Asia Pacific Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
7.4.3. Asia Pacific Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
7.4.4. Asia Pacific Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America Stem Cells Market Analysis, 2015 - 2025
7.5.1. Latin America Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
7.5.2. Latin America Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
7.5.3. Latin America Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
7.5.4. Latin America Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Stem Cells Market Analysis, 2015 - 2025
7.6.1. MEA Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
7.6.2. MEA Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
7.6.3. MEA Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
7.6.4. MEA Stem Cells Market, by Region, 2015 - 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Advanced Cell Technology, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. BIOTIME, Inc.
8.3. BrainStorm Cell Therapeutics
8.4. Caladrius
8.5. Cellartis AB
8.6. Celgene Corporation
8.7. CellGenix GmbH
8.8. Gamida Cell
8.9. Genea BioCells
8.10. Lonza
8.11. PromoCell GmbH
8.12. Pluristem
8.13. TiGenix
8.14. Waisman Biomanufacturing

List of Figures
Fig. 1 Stem Cells: Market Segmentation
Fig. 2 Global Stem Cells Market Share, by Product, 2016 (Value %)
Fig. 3 Global Stem Cells Market Share, by Application, 2016 (Value %)
Fig. 4 Global Stem Cells Market Share, by Therapy, 2016 (Value %)
Fig. 5 Global Stem Cells Market Share, by Geography, 2016 (Value %)
Fig. 6 Attractive Investment Proposition, by Geography
Fig. 7 Market Competition Landscape, by Key Players, 2016
Fig. 8 Global Adult Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 9 Global Neuronal Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 10 Global Hematopoietic Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 11 Global Mesenchymal Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 12 Global Umbilical Cord Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 13 Global Others Adult Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 14 Global Human Embryonic Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 15 Global Induced Pluripotent Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 16 Global Very Small Embryonic Like Stem Cells Market 2015 - 2025 (US$ Mn)
Fig. 17 Global Regenerative Medicine Market 2015 - 2025 (US$ Mn)
Fig. 18 Global Neurology Market 2015 - 2025 (US$ Mn)
Fig. 19 Global Orthopedics Market 2015 - 2025 (US$ Mn)
Fig. 20 Global Oncology Market 2015 - 2025 (US$ Mn)
Fig. 21 Global Hematology Market 2015 - 2025 (US$ Mn)
Fig. 22 Global Cardiovascular Diseases Market 2015 - 2025 (US$ Mn)
Fig. 23 Global Diabetes Market 2015 - 2025 (US$ Mn)
Fig. 24 Global Liver Disorders Market 2015 - 2025 (US$ Mn)
Fig. 25 Global Others Regenerative Medicine Market 2015 - 2025 (US$ Mn)
Fig. 26 Global Drug Discovery and Development Market 2015 - 2025 (US$ Mn)
Fig. 27 Global Autologous Stem Cells Therapy Market 2015 - 2025 (US$ Mn)
Fig. 28 Global Allogeneic Stem Cells Therapy Market 2015 - 2025 (US$ Mn)
Fig. 29 U.S. Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 30 Canada Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 31 U.K. Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 32 Germany Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 33 France Stem Cells Market, 2015-2025 (US$ Mn)
Fig. 34 Rest of Europe Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 35 Japan Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 36 China Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 37 India Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 38 Rest of Asia Pacific Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 39 Brazil Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 40 Mexico Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 41 Rest of Latin America Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 42 GCC Stem Cells Market, 2015 - 2025 (US$ Mn)
Fig. 43 Rest of Middle East and Africa Stem Cells Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
Table 2 Global Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
Table 3 Global Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
Table 4 Global Stem Cells Market, by Geography, 2015 - 2025 (US$ Mn)
Table 5 North America Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
Table 6 North America Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
Table 7 North America Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
Table 8 North America Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
Table 9 Europe Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
Table 10 Europe Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
Table 11 Europe Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
Table 12 Europe Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
Table 13 Asia Pacific Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
Table 14 Asia Pacific Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
Table 15 Asia Pacific Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
Table 16 Asia Pacific Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
Table 17 Latin America Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
Table 18 Latin America Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
Table 19 Latin America Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
Table 20 Latin America Stem Cells Market, by Country, 2015 - 2025 (US$ Mn)
Table 21 Middle East and Africa Stem Cells Market, by Product, 2015 - 2025 (US$ Mn)
Table 22 Middle East and Africa Stem Cells Market, by Application, 2015 - 2025 (US$ Mn)
Table 23 Middle East and Africa Stem Cells Market, by Therapy, 2015 - 2025 (US$ Mn)
Table 24 Middle East and Africa Stem Cells Market, by Region, 2015 - 2025 (US$ Mn)
Table 25 Advanced Cell Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 26 BIOTIME, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 27 BrainStorm Cell Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 28 Caladrius: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 29 Cellartis AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 30 Celgene Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 31 CellGenix GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 32 Gamida Cell: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 33 Genea BioCells: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 34 Lonza: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 35 PromoCell GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 36 Pluristem: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 37 TiGenix: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 38 Waisman Biomanufacturing: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Advanced Cell Technology, Inc.
  • BIOTIME, Inc.
  • BrainStorm Cell Therapeutics
  • Caladrius
  • Cellartis AB
  • Celgene Corporation
  • CellGenix GmbH
  • Gamida Cell
  • Genea BioCells
  • Lonza
  • PromoCell GmbH
  • Pluristem
  • TiGenix
  • Waisman Bioman
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll